Vergoeding 2020-2024 voor ATC-subgroep L02AE : Gonadoreline-analogen
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| L02AE01 Busereline (Suprefact ®) | 874.830 | 618.820 | 764.100 | 545.190 | 31.213 |
| L02AE02 Leuproreline (Lucrin pds ®) | 15.533.600 | 12.108.100 | 11.742.000 | 11.809.600 | 12.100.000 |
| L02AE03 Gosereline (Zoladex ®) | 13.356.500 | 12.678.500 | 13.262.900 | 13.512.900 | 13.508.400 |
| L02AE04 Triptoreline (Pamorelin ®) | 4.296.100 | 5.109.100 | 6.079.100 | 7.122.700 | 7.848.800 |
| Totaal | 34.061.030 | 30.514.520 | 31.848.100 | 32.990.390 | 33.488.413 |